Cameco stock gains 5.06 percent as Q3 date approaches

Published on 10/06/2026 at 16:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cameco stock was trading at USD 91.89 on October 6, 2026, at 10:15 a.m. ET. Q2 revenue reached C$813.77 million, while Q3 results are set for October 30.

CCJ, CA13321L1085, Illustration mit AI erstellt.

Cameco Corporation (ISIN CA13321L1085) stock was trading at USD 91.89 on the NYSE on October 6, 2026, at 10:15 a.m. ET, up 5.06 percent from the previous close of USD 87.47. The next earnings date is October 30, when the uranium producer is scheduled to report its Q3 2026 results.

Q3 date follows a difficult quarter

Cameco's Q2 2026 revenue was C$813.77 million, according to MarketBeat in its October 5, 2026 report. The same report cited quarterly earnings per share of C$0.18 and a net margin of 10.21 percent.

That result gives the October 30 report a clear checkpoint: investors will be looking for evidence that higher uranium prices are reaching Cameco's earnings after costs and sales volumes weighed on Q2. The scheduled report is listed for before the market opens, with a conference call on November 4, 2026, according to MarketBeat.

Westinghouse adds strategic weight

Cameco also has exposure beyond uranium mining through its Westinghouse investment. On September 30, 2026, the company acknowledged a US and South Korea framework that anticipates US$120 billion of Korean investment for Westinghouse reactor technology and contemplates up to eight reactors in the United States, as reported in a StockTitan filing summary.

The framework is not a direct Cameco sales contract, but it underscores why Westinghouse matters to the company valuation. Cameco operates across uranium, fuel services and nuclear reactor technology, leaving the Q3 report to connect the strategic story with actual revenue, margins and cash generation.

Stock remains below yearly high

At USD 91.89, Cameco stock stood 32.1 percent below its 52-week high of USD 135.24 and USD 14.19 above its 52-week low of USD 77.70 on October 6, 2026. Trading volume had reached 1,292,359 shares, while the market capitalization was USD 40.0 billion.

The analyst backdrop remains constructive but uses the Toronto-listed share price rather than the NYSE quotation. MarketBeat reported a Buy consensus from 15 analysts, including two Strong Buy ratings, 11 Buy ratings and two Hold ratings, with an average target of C$179.89. National Bank Financial assigned an Outperform rating and a C$185.00 target on October 5, 2026, but the Canadian-dollar target is not directly comparable with the USD 91.89 NYSE price.

October 30 is the next test

Cameco's immediate investor story therefore combines a 5.06 percent session gain with a still-wide gap to the yearly high and a fresh earnings date. The October 30 release will show whether the company's operating figures are beginning to reflect the stronger uranium market and the longer-term value of its nuclear technology assets.